Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse.

You must read this new presentation from Porter Stansberry.

Arthur J. Higgins net worth and biography

Arthur Higgins Biography and Net Worth

Director of Zimmer Biomet

Consultant, Blackstone Healthcare Partners of The Blackstone Group since June 2010. Mr. Higgins served as Non-Executive Chairman of the Board of Assertio Holdings, Inc., successor issuer to Assertio Therapeutics, Inc., from May 2020 until December 2020. Prior to that, he served as President and Chief Executive Officer and a member of the board of directors of Assertio Therapeutics, Inc. from March 2017 until its merger with Zyla Life Sciences in May 2020. Previously, Mr. Higgins served as Chairman of the Board of Management of Bayer HealthCare AG from January 2006 to May 2010 and Chairman of the Bayer HealthCare Executive Committee from July 2004 to May 2010. Prior to joining Bayer HealthCare in 2004, Mr. Higgins served as Chairman, President and Chief Executive Officer of Enzon Pharmaceuticals, Inc. from 2001 to 2004. Prior to that, Mr. Higgins spent 14 years with Abbott Laboratories, most recently as President of the Pharmaceutical Products Division from 1998 to 2001. He graduated from Strathclyde University, Scotland and holds a B.S. in biochemistry.

What is Arthur J. Higgins' net worth?: The estimated net worth of Arthur J. Higgins is at least $2.79 million as of May 6th, 2024. Mr. Higgins owns 25,548 shares of Zimmer Biomet stock worth more than $2,792,652 as of November 21st. This net worth approximation does not reflect any other assets that Mr. Higgins may own. Learn More about Arthur J. Higgins' net worth.
How do I contact Arthur J. Higgins?: The corporate mailing address for Mr. Higgins and other Zimmer Biomet executives is 345 EAST MAIN STREET, WARSAW IN, 46580. Zimmer Biomet can also be reached via phone at (574) 267-6131 and via email at [email protected]. Learn More on Arthur J. Higgins' contact information.
Has Arthur J. Higgins been buying or selling shares of Zimmer Biomet?: Arthur J. Higgins has not been actively trading shares of Zimmer Biomet during the past quarter. Learn More on Arthur J. Higgins' trading history.
Who are Zimmer Biomet's active insiders?: Zimmer Biomet's insider roster includes Betsy Bernard (Director), Wilfred can Zuilen (Insider), Robert Hagemann (Director), Bryan Hanson (CEO), Arthur Higgins (Director), Sreelakshmi Kolli (Director), Michael Michelson (Director), Chad Phipps (VP), and Sang Yi (Insider). Learn More on Zimmer Biomet's active insiders.
Are insiders buying or selling shares of Zimmer Biomet?: During the last year, insiders at the medical equipment provider sold shares 1 times. They sold a total of 26,156 shares worth more than $3,364,184.72. The most recent insider tranaction occured on February, 22nd when VP Chad F Phipps sold 26,156 shares worth more than $3,364,184.72. Insiders at Zimmer Biomet own 0.7% of the company. Learn More about insider trades at Zimmer Biomet.
Information on this page was last updated on 2/22/2024.

Arthur J. Higgins Insider Trading History at Zimmer Biomet

Arthur J. Higgins Buying and Selling Activity at Zimmer Biomet

Zimmer Biomet Company Overview

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Today's Range

Now: $108.96

$108.68

$109.48

50 Day Range

MA: $106.65

$101.77

$113.02

2 Week Range

Now: $108.96

$101.47

$133.90

Volume

250,431 shs

Average Volume

1,492,234 shs

Market Capitalization

$21.69 billion

P/E Ratio

20.71

Dividend Yield

0.87%

Beta

1.02

This company will win the AI race

From Porter & Company | Ad